Oman Medical Journal · 2019 · 23 citations · 43 references
Health ProfessionsHealth SciencesPharmacotherapyClinical MedicineClinical PharmacologyPatient SafetyAccess To MedicinesEssential MedicinesHuman HealthMedication UsePatient AdherenceTreatment AdherenceChi-square TestHydroxyurea TherapyMedication Adherence SafetyProduct Safety ProfileSafety Profile CharacterizationSickle Cell Disease ManagementTreatment Of Sick
OBJECTIVES: Many barriers contribute to the underutilization of hydroxyurea (HU) in the treatment of sickle cell disease (SCD), and adherence to its use is often reported to be suboptimal. It is important to have information on the safety of HU in patients with SCD. Our study assessed the pattern of use, patients' adherence to medication, discontinuation of use, and safety of HU in patients with SCD. METHODS: This cross-sectional study was conducted in the department of medicine of a referral hospital in Oman over five months and included a review of patient files and patient interview. Approval was obtained from the Regional Research and Ethics Committee of the A'Dakhiliyah Governorate and the hospital administration. The parameters were compared between groups using the chi-square test. RESULTS: 0.015). CONCLUSIONS: Among the current users of HU, the majority of the patients were adherent based on self-reported medication adherence. The prevalence of discontinuation of HU use and instances of non-initiation of HU among those indicated were high. A larger study, ideally of a prospective nature, in various governorates of Oman, would provide a wider picture at the national level.
43
Depression and Medication Adherence in Outpatients With Coronary Heart Disease
Anil K. Gehi, Donald Haas, Sharon Pipkin et al. · Archives of Internal Medicine · 2005 · 497 citations · Full text
Medicine, Cardiology, Psychiatry +14
The Management of Sickle Cell Disease
Joseph Telfair · 2002 · 241 citations